The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women

Internal Medicine

Volumn 48, Issue 13, 2009, Pages 1127-1134

  Oda, Eiji ^a   Kawai, Ryu ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

Diabetes; Inflammation; Metabolic syndrome; White blood cell count

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; JAPANESE; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAL CAPACITY; WAIST CIRCUMFERENCE;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INFLAMMATION; JAPAN; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 67650655899     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2138     Document Type: Article

References (29)

1. Doi Y, Wakugawa Y, Kiyohara Y, et al. Elevated C-reactive protein is a predictor of diabetes in a general Japanese population: the Hisayama study. Diabetes Care 28: 2497-2500, 2005.
2. Ridker PM, Wilson PWF, Grandy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109: 2818-2825, 2004.
3. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005 (Erratum in: Circulation 112: e297, 2005).
4. Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006.
5. The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 94: 794-809, 2005 (in Japanese).
6. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications. report of a WHO Consultation. World Health Org, Geneva, 1999.
7. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
8. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304, 2005.
9. Grundy SM. Does the metabolic syndrome exist? Diabetes Care 29: 1689-1692, 2006.
10. Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care 29: 1693-1696, 2006.
11. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83: 1237-1247, 2006.
12. Sattar N. Why metabolic syndrome criteria have not made prime time: a view from the clinic. Int J Obes (London) 32 (S2): S30-S 34, 2008.
13. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31: 1285-1293, 2008.
14. Kotronen A, Yki-Jarvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thrommb Vasc Biol 28: 27-38, 2008.
15. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004.
16. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 370: 797-799, 2007.
17. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51: 1005-1015, 2002.
18. Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: Disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101: 27-39, 2007.
19. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454, 2005.
20. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006.
21. Nagasawa N, Tamakoshi K, Yatsuya H, et al. Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 68: 892-897, 2004.
22. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by Japanese criteria. Intern Med 46: 1167-1170, 2007.
23. Tamakoshi K, Toyoshima H, Yatsuya H, et al. White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese. Results from NIPPON DATA90. Circ J 71: 479-485, 2007.
24. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 165: 500-508, 2005.
25. Benowitz NL, Sharp DS. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation 80: 1309-1312, 1989.
26. Lee DH, Ha MH, Kim JP, Jacobs DR Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension. Hypertension 37: 194-198, 2001.
27. Tozawa M, Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 30: 937-943, 2007.
28. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 26: 610-615, 1995.
29. Yeh H, Punjabi NM, Wang N, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes. The atherosclerosis risk in communities study. Diabetes Care 28: 1472-1479, 2005.